4th Quarter - Report

AVANIR PHARMACEUTICALS for AVANIR PHARMACEUTICALS

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

21st Century Cures, Post-Acute Care Reform

LobbyistCovered position, as disclosed
SARAH CHRISTINE D'ORSIE Director of Advocacy
CRYSTAL LYNN VANUCH Head of Government Affairs

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.